167 related articles for article (PubMed ID: 20878267)
1. Fast point-of-care coagulometer guided reversal of oral anticoagulation at the bedside hastens management of acute subdural hemorrhage.
Rizos T; Jenetzky E; Herweh C; Unterberg A; Hacke W; Veltkamp R
Neurocrit Care; 2010 Dec; 13(3):321-5. PubMed ID: 20878267
[TBL] [Abstract][Full Text] [Related]
2. Point-of-care reversal treatment in phenprocoumon-related intracerebral hemorrhage.
Rizos T; Jenetzky E; Herweh C; Hug A; Hacke W; Steiner T; Veltkamp R
Ann Neurol; 2010 Jun; 67(6):788-93. PubMed ID: 20517940
[TBL] [Abstract][Full Text] [Related]
3. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
Yasaka M; Sakata T; Naritomi H; Minematsu K
Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
[TBL] [Abstract][Full Text] [Related]
4. Point-of-care international normalized ratio testing accelerates thrombolysis in patients with acute ischemic stroke using oral anticoagulants.
Rizos T; Herweh C; Jenetzky E; Lichy C; Ringleb PA; Hacke W; Veltkamp R
Stroke; 2009 Nov; 40(11):3547-51. PubMed ID: 19696414
[TBL] [Abstract][Full Text] [Related]
5. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation.
Endres K; St Bernard R; Chin-Yee I; Hsia C; Lazo-Langner A
Hematology; 2020 Dec; 25(1):489-493. PubMed ID: 33317427
[TBL] [Abstract][Full Text] [Related]
7. Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience.
Barillari G; Pasca S; Barillari A; De Angelis V
Blood Transfus; 2012 Jan; 10(1):87-94. PubMed ID: 22044952
[TBL] [Abstract][Full Text] [Related]
8. Rapid bedside coagulometry prior to urgent neurosurgical procedures in anticoagulated patients.
Beynon C; Jakobs M; Rizos T; Unterberg AW; Sakowitz OW
Br J Neurosurg; 2014 Jan; 28(1):29-33. PubMed ID: 24313307
[TBL] [Abstract][Full Text] [Related]
9. Prothrombin complex concentrate accelerates international normalized ratio reversal and diminishes the extension of intracranial hemorrhage in geriatric trauma patients.
Edavettal M; Rogers A; Rogers F; Horst M; Leng W
Am Surg; 2014 Apr; 80(4):372-6. PubMed ID: 24887668
[TBL] [Abstract][Full Text] [Related]
10. Point of care coagulometry in prehospital emergency care: an observational study.
Beynon C; Erk AG; Potzy A; Mohr S; Popp E
Scand J Trauma Resusc Emerg Med; 2015 Aug; 23():58. PubMed ID: 26260487
[TBL] [Abstract][Full Text] [Related]
11. Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0.
Zemrak WR; Smith KE; Rolfe SS; May T; Trowbridge RL; Hayes TL; Grindlinger GA; Seder DB
Neurocrit Care; 2017 Dec; 27(3):334-340. PubMed ID: 28660341
[TBL] [Abstract][Full Text] [Related]
12. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation.
Riess HB; Meier-Hellmann A; Motsch J; Elias M; Kursten FW; Dempfle CE
Thromb Res; 2007; 121(1):9-16. PubMed ID: 17407788
[TBL] [Abstract][Full Text] [Related]
13. Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal.
Baggs JH; Patanwala AE; Williams EM; Erstad BL
Ann Pharmacother; 2012 Jan; 46(1):51-6. PubMed ID: 22190253
[TBL] [Abstract][Full Text] [Related]
14. Four-factor prothrombin complex concentrate dose response relationship with INR for warfarin reversal.
Yohe AS; Livings SE
Am J Emerg Med; 2019 Aug; 37(8):1534-1538. PubMed ID: 31130370
[TBL] [Abstract][Full Text] [Related]
15. Self-management of oral anticoagulation therapy--methodological and clinical aspects.
Christensen TD
Dan Med Bull; 2011 May; 58(5):B4284. PubMed ID: 21535992
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center.
Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM
J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428
[TBL] [Abstract][Full Text] [Related]
17. Reliability of point-of-care coagulometer measurements in patients with acute ischaemic stroke receiving intravenous fibrinolysis.
Guisado-Alonso D; Fayos-Vidal F; Martí-Fàbregas J; Prats-Sánchez L; Marín-Bueno R; Martínez-Domeño A; Delgado-Mederos R; Camps-Renom P
Neurologia (Engl Ed); 2020 Apr; 35(3):155-159. PubMed ID: 28958393
[TBL] [Abstract][Full Text] [Related]
18. Prospective Evaluation of a Fixed-Dose 4-Factor Prothrombin Complex Concentrate Protocol for Urgent Vitamin K Antagonist Reversal.
Bitonti MT; Rumbarger RL; Absher RK; Curran LM
J Emerg Med; 2020 Feb; 58(2):324-329. PubMed ID: 31787372
[TBL] [Abstract][Full Text] [Related]
19. Is there a difference in efficacy, safety, and cost-effectiveness between 3-factor and 4-factor prothrombin complex concentrates among trauma patients on oral anticoagulants?
Mangram A; Oguntodu OF; Dzandu JK; Hollingworth AK; Hall S; Cung C; Rodriguez J; Yusupov I; Barletta JF
J Crit Care; 2016 Jun; 33():252-6. PubMed ID: 27021851
[TBL] [Abstract][Full Text] [Related]
20. Correction factor to improve agreement between point-of-care and laboratory International Normalized Ratio values.
Johnson SA; Vazquez SR; Fleming R; Lanspa MJ
Am J Health Syst Pharm; 2017 Jan; 74(1):e24-e31. PubMed ID: 28007718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
